These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 10481009)

  • 1. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy.
    Komarov PG; Komarova EA; Kondratov RV; Christov-Tselkov K; Coon JS; Chernov MV; Gudkov AV
    Science; 1999 Sep; 285(5434):1733-7. PubMed ID: 10481009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer research. A new way to combat therapy side effects.
    Ferber D
    Science; 1999 Sep; 285(5434):1651, 1653. PubMed ID: 10523177
    [No Abstract]   [Full Text] [Related]  

  • 3. Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation.
    Strom E; Sathe S; Komarov PG; Chernova OB; Pavlovska I; Shyshynova I; Bosykh DA; Burdelya LG; Macklis RM; Skaliter R; Komarova EA; Gudkov AV
    Nat Chem Biol; 2006 Sep; 2(9):474-9. PubMed ID: 16862141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of p53: a new approach to overcome side effects of antitumor therapy.
    Komarova EA; Gudkov AV
    Biochemistry (Mosc); 2000 Jan; 65(1):41-8. PubMed ID: 10702639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pifithrin-alpha promotes p53-mediated apoptosis in JB6 cells.
    Kaji A; Zhang Y; Nomura M; Bode AM; Ma WY; She QB; Dong Z
    Mol Carcinog; 2003 Jul; 37(3):138-48. PubMed ID: 12884365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid beta-peptide.
    Culmsee C; Zhu X; Yu QS; Chan SL; Camandola S; Guo Z; Greig NH; Mattson MP
    J Neurochem; 2001 Apr; 77(1):220-8. PubMed ID: 11279278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of p53 response in tumor stroma improves efficacy of anticancer treatment by increasing antiangiogenic effects of chemotherapy and radiotherapy in mice.
    Burdelya LG; Komarova EA; Hill JE; Browder T; Tararova ND; Mavrakis L; DiCorleto PE; Folkman J; Gudkov AV
    Cancer Res; 2006 Oct; 66(19):9356-61. PubMed ID: 17018587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [PFTalpha, guardian of the sick?].
    Jacquemin-Sablon A
    Bull Cancer; 1999 Nov; 86(11):894-5. PubMed ID: 10627130
    [No Abstract]   [Full Text] [Related]  

  • 9. Pifithrin-alpha, an inhibitor of p53, enhances the genetic instability induced by etoposide (VP16) in human lymphoblastoid cells treated in vitro.
    Bassi L; Carloni M; Fonti E; Palma de la Peña N; Meschini R; Palitti F
    Mutat Res; 2002 Feb; 499(2):163-76. PubMed ID: 11827710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of p53 protects liver tissue against endotoxin-induced apoptotic and necrotic cell death.
    Schäfer T; Scheuer C; Roemer K; Menger MD; Vollmar B
    FASEB J; 2003 Apr; 17(6):660-7. PubMed ID: 12665479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A chemical inhibitor of p53 that protects mice from the side effects of cancer treatment].
    Stadler P; Grosu AL; Molls M
    Strahlenther Onkol; 2000 Feb; 176(2):98. PubMed ID: 10697660
    [No Abstract]   [Full Text] [Related]  

  • 12. Prospective therapeutic applications of p53 inhibitors.
    Gudkov AV; Komarova EA
    Biochem Biophys Res Commun; 2005 Jun; 331(3):726-36. PubMed ID: 15865929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pifithrin-alpha suppresses p53 and protects cochlear and vestibular hair cells from cisplatin-induced apoptosis.
    Zhang M; Liu W; Ding D; Salvi R
    Neuroscience; 2003; 120(1):191-205. PubMed ID: 12849752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The p53 inhibitor pifithrin-alpha is a potent agonist of the aryl hydrocarbon receptor.
    Hoagland MS; Hoagland EM; Swanson HI
    J Pharmacol Exp Ther; 2005 Aug; 314(2):603-10. PubMed ID: 15843497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual effect of p53 on radiation sensitivity in vivo: p53 promotes hematopoietic injury, but protects from gastro-intestinal syndrome in mice.
    Komarova EA; Kondratov RV; Wang K; Christov K; Golovkina TV; Goldblum JR; Gudkov AV
    Oncogene; 2004 Apr; 23(19):3265-71. PubMed ID: 15064735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The p53-reactivating small-molecule RITA enhances cisplatin-induced cytotoxicity and apoptosis in head and neck cancer.
    Roh JL; Ko JH; Moon SJ; Ryu CH; Choi JY; Koch WM
    Cancer Lett; 2012 Dec; 325(1):35-41. PubMed ID: 22634494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of tumor suppressor p53 decreases PTEN expression and enhances signaling pathways leading to activation of activator protein 1 and nuclear factor kappaB induced by UV radiation.
    Wang J; Ouyang W; Li J; Wei L; Ma Q; Zhang Z; Tong Q; He J; Huang C
    Cancer Res; 2005 Aug; 65(15):6601-11. PubMed ID: 16061640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of the ability of pifithrin-alpha and -beta to inhibit p53 function in two wild-type p53 human tumor cell lines.
    Walton MI; Wilson SC; Hardcastle IR; Mirza AR; Workman P
    Mol Cancer Ther; 2005 Sep; 4(9):1369-77. PubMed ID: 16170029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Aza-cytidine is a potent inhibitor of DNA methyltransferase 3a and induces apoptosis in HCT-116 colon cancer cells via Gadd45- and p53-dependent mechanisms.
    Schneider-Stock R; Diab-Assef M; Rohrbeck A; Foltzer-Jourdainne C; Boltze C; Hartig R; Schönfeld P; Roessner A; Gali-Muhtasib H
    J Pharmacol Exp Ther; 2005 Feb; 312(2):525-36. PubMed ID: 15547111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical-mediated inactivation of p53 sensitizes U87MG glioma cells to BCNU and temozolomide.
    Xu GW; Mymryk JS; Cairncross JG
    Int J Cancer; 2005 Aug; 116(2):187-92. PubMed ID: 15800902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.